Search

everythinglearnresearchcommunity

for

Search:↓

Wigs significantly improve the well-being of people with severe hair loss.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

CEOs aged 50-69 have less significant hair loss than the general white male population.

CEOs aged 50-69 have less significant hair loss than the general white male population.

Spironolactone was effective in reducing hair growth in women with hirsutism.

Low vitamin D levels are linked to higher rates of hair loss in women.

More severe hair loss worsens quality of life in men.

Hair loss in women in Lagos, Nigeria is rare but severe when it occurs, with symptoms similar to those seen worldwide.

Hair loss in women in Lagos, Nigeria is not common, but when it happens, it's usually severe.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Hairpieces improve quality of life for women with hair loss.

Eyebrow and eyelash hair loss in alopecia areata worsens quality of life.

rTMS may help treat trichotillomania in some patients.

Hair regrowth improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Low-dose Minoxidil combined with Spironolactone helps reduce hair loss and improve hair density in women, with some mild side effects.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

Minoxidil 0.25 mg with spironolactone 25 mg reduces hair loss and improves hair density in women.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

Finasteride and dutasteride can cause severe, lasting side effects.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

Nail changes are common in alopecia areata and can indicate its severity.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.